Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: J Clin Psychiatry. 2015 Jun;76(6):e787–e793. doi: 10.4088/JCP.14m09299

Table 1.

Demographic and Clinical Characteristics at Study Entry Across Group

Characteristic d-Cycloserine (n = 20),
Mean (SD)
Placebo (n = 16),
Mean (SD)
Combined (N = 36),
Mean (SD)
Statistica Pa
Age, y 26.10 (10.53) 24.63 (8.96) 25.44 (9.75) t = 0.44 .659
BMI 20.10 (2.13) 20.44 (1.91) 20.25 (2.09) t = 0.28 .782
Scores on EDI-2
  Drive for thinness 16.85 (7.00) 21.19 (6.25) 18.78 (6.93) t = 1.93 .071
  Bulimic symptoms 6.95 (6.95) 6.12 (5.80) 6.58 (6.38) t = 0.38 .706
  Body dissatisfaction 18.10 (7.73) 20.88 (4.98) 19.33 (6.71) t = 1.24 .223
Scores on BDI-II
  Depression 33.10 (10.02) 34.50 (9.10) 33.74 (9.50) t = 0.43 .672
Diagnoses n (%) n (%) n (%)



  BMI ≥ 18.5 15 (75.0) 14 (87.5) 29 (80.6) χ2 = 0.887 .346
  Anxiety disorder 15 (75.0) 15 (93.8) 30 (83.3) χ2 = 1.55 .213
  Depressive disorder 15 (75.0) 13 (81.3) 28 (77.8) χ2 = 0.83 .662
a

There are no significant differences across condition. However, we should note that there are slight differences (though nonsignificant) in drive for thinness, body dissatisfaction, and in the numbers of participants whose BMI equaled or exceeded 18.5 and who were diagnosed with a comorbid anxiety disorder.

Abbreviations: BDI-II = Beck Depression Inventory, 2nd revision, BMI = body mass index, EDI-2 = Eating Disorder Inventory, 2nd revision.